News

Medical Connections has finalised all of the systems implementation and integration with ERP software. The company engaged the services of Tribridge in early 2009, to help develop an

Pacific Biosciences has received grants totaling more than $1.9m from the National Institutes of Health (NIH), as part of the American Recovery & Reinvestment Act of 2009 Research

Idera Pharmaceuticals (Idera) has initiated phase I clinical trial for IMO-2125 in combination with ribavirin for the treatment of naive patients with chronic hepatitis C virus (HCV) infection.

Synexus has reportedted that it has already run several large late phase clinical trials for cancer vaccines and has a tried and tested recruitment methodology, which rapidly finds

Nutra Pharma has revealed plans to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain. Nyloxin Rx is a prescription pain reliever

Mannatech has secured a second injunction in its ongoing efforts to protect its glyconutrient products – Ambrotose complex and Advanced Ambrotose formula. The company said that the US

The European Commission (EC) has granted marketing authorisation to Baxter International for Celvapan H1N1 pandemic vaccine, using the company’s Vero cell technology. Reportedly, Baxter continues to deliver vaccine

Kylin Therapeutics have received a notice of allowance from the US Patent and Trademark Office for its first US patent application. The newly allowed patent, exclusively licensed to

Relypsa has initiated patient enrollment in the PEARL-HF study, a phase 2b clinical trial of the company’s lead compound, RLY5016. Its a novel potassium binder designed for chronic